Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
329.63+56.24 (+20.57%)
At close: 1:00PM EST
336.15 +6.52 (+1.98%)
After hours: 04:59PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close273.39
Open319.34
Bid336.05 x 1400
Ask336.48 x 900
Day's Range313.00 - 350.15
52 Week Range102.66 - 497.49
Volume35,901,209
Avg. Volume12,936,852
Market Cap133.648B
Beta (5Y Monthly)1.31
PE Ratio (TTM)19.75
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-19% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MRNA

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Moderna, Inc.
    Analyst Report: Moderna, Inc.Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
All
News
Press Releases
Advertisement
Advertisement